Liotrix

DB01583ApprovedSmall moleculel-TriiodothyronineThyroid Products

Liotrix is a synthetically derived thyroid hormone replacement preparation. It consists of levothyroxine sodium (thyroxine, T4) and liothyronine sodium (triiodothyronine, T3) in a 4 to 1 ratio by weight. Liotrix... Liotrix was developed when it was believed that serum levels of both T4 and T3 were maintained by direct thyroidal secretion.

Chemical structure of Liotrix
Mechanism
Curator reviewed
Primary indication
May be used to treat primary, secondary or tertiary hypothyroidism.Curator reviewed
Formula / weight
C30H21I7N2Na2O8 · 1471.8072 g/mol (avg)
Also known as
Levothyroxine Sodium mixture with Liothyronine Sodium · Liotrix (T4;T3)
Code names
W 1782

Resolves to

Clinical / RWD
Structure
InChIKeyLKYWLLWWYBVUPP-XOCLESOZSA-LSMILES[Na+].[Na+].N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C([O-])=O.N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C([O-])=O

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
11TransportersSubstrate / inhibitor direction, not just membership
Listed above
763Drug interactionsStructured to mechanism, not free text
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
43+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Liotrix, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account